Integrative Analysis of Differently Expressed Genes Reveals a 17-Gene Prognosis Signature for Endometrial Carcinoma

Figure 4

Identification of DEGs related to poor prognosis in EC. (a–s) Among these genes, higher expressions of BEX4, ERFE, FBXO17, GLDC, MAL2, MCM10, METTL7B, OAS1, POLQ, PSAT1, PSD3, PTTG1, RAPGEF4, SIMC1, SRPX, TIMP3, TRO, TRPC1, and UST were correlated to shorter OS time in patients with EC.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)

(p)

(q)

(r)

(s)